참고문헌
- Sanchez YP, Rodriguez DR. Tuberculosis meningitis, still misunderstood. J Neuroinfect Dis 2015;S2:005.
- Mai NT, Dobbs N, Phu NH, Colas RA, Thao LT, Thuong NT, et al. A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIVuninfected adults. Elife 2018;7:e33478. https://doi.org/10.7554/elife.33478
- Thwaites GE, van Toorn R, Schoeman J. Tuberculous meningitis: more questions, still too few answers. Lancet Neurol 2013;12:999-1010. https://doi.org/10.1016/S1474-4422(13)70168-6
- World Health Organization. Global tuberculosis report 2017. WHO/PDF/TB/2018 [Internet]. Geneva: World Health Organization; 2018 [cited 2018 Sep 26]. Available from: https://www.who.int/tb/publications/global_report/en/.
- Gao M, Gao J, Du J, Liu Y, Zhang Y, Ma L, et al. Efficacy of ultra-short course chemotherapy for new smear positive drug susceptible pulmonary tuberculosis: study protocol of a multicenter randomized controlled clinical trial. BMC Infect Dis 2017;17:435. https://doi.org/10.1186/s12879-017-2505-7
- World Health Organization. Guidelines for treatment of drug-susceptible tuberculosis and patient care. WHO/PDF/TB/2017 [Internet]. Geneva: World Health Organization; 2017 [cited 2017 Apr 1]. Available from: https://www.who.int/tb/publications/2017/dstb_guidance_2017/en/.
- Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, et al. Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an openlabel, randomised controlled phase 2 trial. Lancet Infect Dis 2013;13:27-35. https://doi.org/10.1016/S1473-3099(12)70264-5
- Butov DO, Zaitseva SI, Pitenko MM, Stepanenko GL, Butova TS. Morphological changes in experimental tuberculosis resulting from treatment with quercetin and polyvinylpyrrolidone. Int J Mycobacteriol 2015;4:296-301. https://doi.org/10.1016/j.ijmyco.2015.08.003
- Begley DJ. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities. Pharmacol Ther 2004;104:29-45. https://doi.org/10.1016/j.pharmthera.2004.08.001
- Butov D, Feshchenko Y, Kuzhko M, Gumeniuk M, Butova T. Efficacy and safety of intravenous chemotherapy during intensive treatment phase in patients with newly diagnosed pulmonary tuberculosis. Adv Respir Med 2018;86:159-67.
- World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. WHO/PDF/TB/2006 [Internet]. Geneva: World Health Organization; 2006 [cited 2006 Aug 7]. Available from: https://www.who.int/hiv/pub/vct/hivstaging/en/.
- World Health Organization. Treatment of tuberculosis: guidelines, 4th ed. WHO/PDF/TB/2010 [Internet]. Geneva: World Health Organization; 2010 [cited 2018 Sep 26]. Available from: https://apps.who.int/iris/bitstream/handle/10665/44165/9789241547833_eng.pdf?sequence=1.
- World Health Organization. HIV/AIDS treatment and care: clinical protocols for the WHO European Region. WHO ER/ PDF/TB/2007 [Internet]. Geneva: World Health Organization European Region; 2007 [cited 2018 Sep 26]. Available from: https://www.who.int/hiv/topics/idu/care/E90840.pdf.
- World Health Organization. Xpert MTB/RIF implementation manual: technical and operational 'how-to': practical considerations. WHO/PDF/TB/2014 [Internet]. Geneva: World Health Organization; 2014 [cited 2018 Sep 26]. Available from: https://www.who.int/tb/publications/xpert_implem_manual/en/.
- Erokhin VV, Kornilova Z, Alekseeva LP. The specific features of the detection, clinical manifestations, and treatment of tuberculosis in the HIV-infected. Probl Tuberk Bolezn Legk 2005:20-8.
- Tsymbalar GG, Botoshanu E, Roshka SN, Burinskaia LP. Clinical picture and treatment of tuberculous meningitis in adults. Probl Tuberk 1983;(3):51-3.
- Lapach SN, Chubenko AV, Babich PN. Statistical methods in biomedical studies using Excel. Kyiv: Morion; 2000.
- Donald PR. Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinb) 2010;90:279-92. https://doi.org/10.1016/j.tube.2010.07.002
- Pouplin T, Bang ND, Toi PV, Phuong PN, Dung NH, Duong TN, et al. Naive-pooled pharmacokinetic analysis of pyrazinamide, isoniazid and rifampicin in plasma and cerebrospinal fluid of Vietnamese children with tuberculous meningitis. BMC Infect Dis 2016;16:144. https://doi.org/10.1186/s12879-016-1470-x
- Nguyen DT, Jenkins HE, Graviss EA. Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients. PLoS One 2018;13:e0196022. https://doi.org/10.1371/journal.pone.0196022
- Kimerling ME, Phillips P, Patterson P, Hall M, Robinson CA, Dunlap NE. Low serum antimycobacterial drug levels in non-HIV-infected tuberculosis patients. Chest 1998;113:1178-83. https://doi.org/10.1378/chest.113.5.1178
- Alsultan A, Peloquin CA. Pharmacokinetics and pharmacodynamics of isoniazid in patients with intermediate resistance. Int J Tuberc Lung Dis 2017;21:121-3. https://doi.org/10.5588/ijtld.16.0689
- Bekker A, Schaaf HS, Draper HR, van der Laan L, Murray S, Wiesner L, et al. Pharmacokinetics of rifampin, isoniazid, pyrazinamide, and ethambutol in infants dosed according to revised WHO-recommended treatment guidelines. Antimicrob Agents Chemother 2016;60:2171-9. https://doi.org/10.1128/AAC.02600-15
피인용 문헌
- Neurologic Complications of Tuberculosis vol.27, pp.4, 2020, https://doi.org/10.1212/con.0000000000001005